MSCL — Satellos Bioscience Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Satellos Bioscience, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	0.065	4.87	1.92	39.6	69.9
Net Total Accounts Receivable
Net Total Receivables	0.449	0.528	0.26	0.583	0.626
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0.543	5.44	2.23	40.3	73
Net Property, Plant And Equipment	0.003	0.008	0.008	0.019	0.005
Net Intangible Assets
Long Term Investments
Total Assets	0.546	12.6	6.2	44.3	73
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	1.3	2.1	2.83	3.62	5.16
Long Term Debt
Total Long Term Debt
Total Debt
Total Liabilities	1.3	2.1	2.83	3.62	5.16
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-0.75	10.5	3.37	40.7	67.9
Total Liabilities & Shareholders' Equity	0.546	12.6	6.2	44.3	73
Total Common Shares Outstanding